HORIZON Research and Innovation Actions

EOSC4Cancer is funded by the European Union’s Horizon Europe research and innovation actions under grant agreement No 101058427

1 September 2022 – 28 February 2025 (30 months)

Barcelona Supercomputing Center (Centro Nacional de Supercomputación)

VIEW PARTNERS >

Academisch Ziekenhuis Groningen, Netherlands

Albert-Ludwigs-Universitaet Freiburg, Germany

Barcelona Supercomputing Center – Centro Nacional De Supercomputación, Spain

Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC), Austria

Centre National De La Recherche Scientifique CNRS, France

Consiglio Nazionale Delle Ricerche, Italy

CSC – Tieteen Tietotekniikan Keskus Oy, Finland

Deutsches Krebsforschungszentrum Heidelberg, Germany

EATRIS ERIC, Netherlands

ECRIN European Clinical Research Infrastructure Network, France

Empirica Gesellschaft Fur Kommunikations Und Technologieforschung mbH, Germany

Erasmus Universitair Medisch Centrum Rotterdam, Netherlands

Ethniko Kentro Erevnas Kai Technologikis Anaptyxis, Greece

EURO-BIOIMAGING ERIC, Finland

European Cancer Patient Coalition, Belgium

European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (EU-OPENSCREEN ERIC), Germany

European Molecular Biology Laboratory, Germany

Fundacio Centre De Regulacio Genomica, Spain

Fundacio Institut de Recerca Biomedica (IRB Barcelona), Spain

Fundacio Privada Institut D’investigacio Oncologica De Vall-Hebron (VHIO), Spain

Fundación Sector Público Estatal Centro Nacional Investigaciones Oncológicas Carlos III, Spain

Infrafrontier GmbH, Germany

INSTRUCT-ERIC, United Kingdom

Karolinska Institutet, Sweden

Masarykova Univerzita, Czech Republic

Stichting DTL Projects, Netherlands

Stichting Het Nederlands Kanker Instituutantoni van Leeuwenhoek Ziekenhuis, Netherlands

Stichting Lygature, Netherlands

The University of Manchester, United Kingdom

Universita degli Studi di Torino, Italy

Universite de Bordeaux, France

Universitetet I Oslo, Norway

Univerzita Palackeho V Olomouci, Czech Republic

Ustav Molekularni Genetiky Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce, Czech Republic

Why it matters

EOSC4Cancer brings together a comprehensive consortium of cancer research centres, research infrastructures, leading research groups, hospitals and supercomputing centres from 14 European countries. To make the developments sustainable, these will be offered as part of the research infrastructures partners services portfolio, in connection with the EOSC ecosystem and to serve the
European Cancer Mission, which will be possible via the engagement with large international coalitions, e.g. ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action and patients/survivors associations.

What ECPC does

ECPC will ensure the dialogue with the patients regarding the shape of the outcomes and lines of the project. Help to identify the challenges related to cancer data services and the patients’ needs. ECPC will contribute to enforce the patient engagement and improve the trust, transparency and bias related to AI use in cancer diagnose and treatment.

EU flag logo

This project has received funding from the European Union’s HORIZON Research and Innovation Actions under grant agreement No 101058427